SecSonar.com

CorMedix Inc. (CRMD)

CorMedix Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CorMedix Inc. (CRMD) is a Biotechnology company based in US with a market capitalization of $659.8M. The company generated $172.8M in free cash flow. This page tracks CRMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 64 employees · IPO May 13, 2010

Valuation

Valuation & price

$7.55 · as of May 17, 2026 · -49.1% vs 52w high

3.7

P/E ratio

Latest-FY diluted EPS

1.63

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$14.83$10.56$6.30Jul 25Dec 25Jul 26Jul 7, 25$11.42Jul 9, 25$11.35Jul 11, 25$11.22Jul 15, 25$11.37Jul 17, 25$11.07Jul 21, 25$10.94Jul 23, 25$11.62Jul 25, 25$11.49Jul 29, 25$11.64Jul 31, 25$11.67Aug 4, 25$12.37Aug 6, 25$11.95Aug 11, 25$10.07Aug 13, 25$12.08Aug 15, 25$12.93Aug 19, 25$13.06Aug 21, 25$13.56Aug 25, 25$13.73Aug 27, 25$14.14Aug 29, 25$14.83Sep 3, 25$13.70Sep 5, 25$12.40Sep 9, 25$13.03Sep 11, 25$13.09Sep 16, 25$11.59Sep 18, 25$11.69Sep 22, 25$11.27Sep 24, 25$11.24Sep 26, 25$11.30Sep 30, 25$11.63Oct 2, 25$11.05Oct 6, 25$11.56Oct 8, 25$11.27Oct 10, 25$10.73Oct 14, 25$10.54Oct 16, 25$10.08Oct 21, 25$11.65Oct 23, 25$11.31Oct 27, 25$11.05Oct 29, 25$11.31Oct 31, 25$11.13Nov 4, 25$11.42Nov 6, 25$10.78Nov 10, 25$11.08Nov 12, 25$11.42Nov 14, 25$11.24Nov 18, 25$10.07Nov 20, 25$9.72Nov 25, 25$9.40Nov 28, 25$9.81Dec 2, 25$9.78Dec 4, 25$10.64Dec 8, 25$11.26Dec 10, 25$11.47Dec 12, 25$11.49Dec 16, 25$11.44Dec 18, 25$11.92Dec 22, 25$12.39Dec 24, 25$12.19Dec 29, 25$12.73Jan 2, 26$12.16Jan 6, 26$11.26Jan 8, 26$7.51Jan 12, 26$7.15Jan 14, 26$7.09Jan 16, 26$6.78Jan 21, 26$7.33Jan 23, 26$7.27Jan 27, 26$7.75Jan 29, 26$8.02Feb 2, 26$8.17Feb 4, 26$7.84Feb 9, 26$7.58Feb 11, 26$7.43Feb 13, 26$7.34Feb 18, 26$7.17Feb 20, 26$7.03Feb 24, 26$7.07Feb 26, 26$7.35Mar 2, 26$7.21Mar 4, 26$7.12Mar 6, 26$6.46Mar 10, 26$6.72Mar 12, 26$6.40Mar 17, 26$6.46Mar 19, 26$6.30Mar 23, 26$6.42Mar 25, 26$6.61Mar 27, 26$6.71Mar 31, 26$6.79Apr 2, 26$7.05Apr 7, 26$7.17Apr 9, 26$7.36Apr 13, 26$7.32Apr 15, 26$7.23Apr 17, 26$7.39Apr 22, 26$7.49Apr 24, 26$7.42Apr 28, 26$7.57Apr 30, 26$7.59May 4, 26$7.90May 6, 26$8.05May 8, 26$7.92May 12, 26$7.51May 14, 26$7.93May 18, 26$7.91May 20, 26$7.93May 22, 26$7.98May 28, 26$8.42Jun 1, 26$8.45Jun 3, 26$8.23Jun 5, 26$8.36Jun 9, 26$8.65Jun 11, 26$8.96Jun 15, 26$8.59Jun 17, 26$8.67Jun 22, 26$8.82Jun 24, 26$8.39Jun 26, 26$7.85Jul 2, 26$8.79
$6.2552-week range$14.83
Loading valuation history…

Fundamentals

Key fundamentals

$659.8M

Market cap

—

Revenue growth (YoY)

88.5%

Gross margin

$172.8M

Free cash flow (USD)

-$605K

Net debt

Net cash position

22.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$224.1KFY 2017$329.3KFY 2018$429.8KFY 2019$283.3KFY 2020$239.2KFY 2021$190.9KFY 2022$65.4KFY 2023$0.00FY 2024$43.5MFY 2025$311.7M
$224.1K$311.7M

Free cash flow by year

2016 → 2025

FY 2016$-22.3MFY 2017$-28.7MFY 2018$-23.7MFY 2019$-15.1MFY 2020$-22.1MFY 2021$-22.6MFY 2022$-24.6MFY 2023$-38.7MFY 2024$-50.7MFY 2025$172.8M
-$22.3M$172.8M

Gross margin by year

2021 → 2025

FY 202122.0%FY 202294.3%FY 202492.7%FY 202588.5%
22.0%88.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $0.43)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventExecutive Leadership ChangeJul 2, 2026Filing
  • 8-K eventAccounting Firm ChangeJul 1, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • 8-K eventPatent Litigation OutcomeJun 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventPhase III Study ResultsApr 27, 2026Filing

Questions

Frequently asked questions

What is CorMedix Inc.'s market cap?

CorMedix Inc. (CRMD) has a market capitalization of $659.8M.

What is CRMD's P/E ratio?

CRMD trades at a price-to-earnings ratio of 3.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is CRMD's price-to-book (P/B) ratio?

CRMD trades at 1.63 times book value per share.

When did CorMedix Inc. last report earnings?

CRMD last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying CRMD stock?

SEC Form 4 filings show no open-market insider buys at CorMedix Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ANL

Adlai Nortye Ltd.

$652.4M

ESPR

Esperion Therapeutics, Inc.

$650.8M

BIOA

BioAge Labs, Inc.

$646.1M

ZVRA

Zevra Therapeutics, Inc.

$684.8M

PRME

Prime Medicine, Inc.

$632.2M

DNA

Ginkgo Bioworks Holdings, Inc.

$628.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.